Live tape
Top 8, mentions 7d10,066TSLA2,067 mentions▲ +0.05GOOGL1,609 mentions▲ +0.04NVDA1,230 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,103 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

ROIV

NASDAQ

Roivant Sciences Ltd.

$40.82 −0.31% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 11, 2026
Price · Chart
32 sessions
$42.5 $32.5 29 Jul 11 Sep

The line runs $32.87 on 29 July through $40.82 on 11 September, on a scale from $32.5 to $42.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 32 sessions, 29 Jul – 11 Sep 2026
Market cap $29.5B
52-week range $12.56 – $41.81
Avg volume 632.7K

as of Sep 11, 2026

ROIV insider trades

SEC Form 4 · last 90 days · newest reported trade 1 Oct 2026
Open-market buys 0
Open-market sells 13
Net sold $59.83M
Non-trade filings 29
Date Insider Type Shares Value
01 Oct 2026 Epperly Melissa B, Director Sell 17,750 $641K
30 Sep 2026 Venker Eric President & Immunovant CEO Sell 200,000 $7.32M
15 Sep 2026 Epperly Melissa B, Director Sell 4,938 $196K
15 Sep 2026 Fitzgerald Meghan Director Sell 5,112 $203K
08 Sep 2026 Fitzgerald Meghan Director Sell 20,000 $798K
28 Aug 2026 Venker Eric President & Immunovant CEO Sell 200,000 $7.15M
21 Aug 2026 Sukhatme Mayukh President & CIO Sell 144,756 $5.28M
20 Aug 2026 Sukhatme Mayukh President & CIO Sell 17,519 $653K
19 Aug 2026 Sukhatme Mayukh President & CIO Sell 172,899 $6.43M
18 Aug 2026 Sukhatme Mayukh President & CIO Sell 136,942 $5.03M
17 Aug 2026 Sukhatme Mayukh President & CIO Sell 284,707 $10.32M
14 Aug 2026 Sukhatme Mayukh President & CIO Sell 243,177 $8.81M

Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2026 Epperly Melissa B, Director Option exercise 17,750 $79K
30 Sep 2026 Gline Matthew CEO Tax withheld 76,171 $2.79M
30 Sep 2026 Torti Frank President and Vant Chair Tax withheld 40,309 $1.47M
30 Sep 2026 Venker Eric President & Immunovant CEO Option exercise 200,000 $770K
30 Sep 2026 Sukhatme Mayukh President & CIO Tax withheld 46,879 $1.71M
20 Sep 2026 Humes Jennifer Chief Accounting Officer Tax withheld 3,880 $154K
20 Sep 2026 Pulik Richard CFO Tax withheld 2,129 $85K
16 Sep 2026 Epperly Melissa B, Director Award 5,054
16 Sep 2026 Fitzgerald Meghan Director Award 5,054
16 Sep 2026 Gold Daniel Allen Director Award 5,054
16 Sep 2026 MANCHESTER KEITH S Director Award 5,054
16 Sep 2026 MOMTAZEE JAMES C Director Award 5,054

Showing the 12 most recent of 29 compensation filings in this window. The figures above count all of them.

ROIV reported financials

SEC EDGAR XBRL SEC EDGAR

ROIV reported revenue of $8.3M for the fiscal year ended 31 Mar 2026. Net income over the same period was −$299.8M.

Figure Reported Period
Revenue $8.3M 31 Mar 2026 fiscal year
Net income −$299.8M 31 Mar 2026 fiscal year
Diluted EPS −$0.54 31 Mar 2026 fiscal year
Total assets $5.3B 30 Jun 2026 at period end
Total equity $4.2B 30 Jun 2026 at period end

ROIV earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q1 2026 −$0.26 $1M
31 Mar 2026 FY 2025 −$0.54 $8M
31 Dec 2025 Q3 2025 −$0.38 $2M
30 Sep 2025 Q2 2025 −$0.17 $2M
30 Jun 2025 Q1 2025 −$0.33 $2M
31 Mar 2025 FY 2024 −$0.24 $29M
31 Dec 2024 Q3 2024 $0.23 $9M
30 Sep 2024 Q2 2024 −$0.31 $4M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ROIV institutional holders

SEC Form 13F SEC EDGAR

12 of the 45 institutional funds we track reported a ROIV position for the quarter ended 30 Jun 2026 — a combined $1.3B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) +11.5% shares 6,633,560 $234.0M
Viking Global Investors Held (±25%) −5.7% shares 6,271,467 $221.9M
Citadel Advisors Added +121.6% shares 5,576,261 $197.3M
Baker Bros. Advisors Held (±25%) −3.1% shares 4,716,831 $166.9M
Point72 Asset Management Added +402.1% shares 4,473,478 $158.3M
D. E. Shaw & Co. Added +113.4% shares 2,972,702 $105.2M
Maverick Capital Added +73.9% shares 2,829,024 $100.1M
Marshall Wace Trimmed −36.7% shares 1,421,478 $50.3M
Millennium Management Held (±25%) −12.9% shares 700,494 $24.8M
Man Group Trimmed −65.9% shares 290,772 $10.3M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

ROIV fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 719 shares of ROIV failed to deliver (about $26K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
28 Sep 2026 719 $26K <0.001%
25 Sep 2026 924 $33K <0.001%
17 Sep 2026 31 $1K <0.001%
16 Sep 2026 36,030 $1.4M 0.005%
15 Sep 2026 5,293 $217K 0.001%
11 Sep 2026 5,306 $217K 0.001%
10 Sep 2026 49,163 $2.1M 0.007%
09 Sep 2026 102,373 $4.2M 0.014%

Congressional trades in ROIV

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in ROIV is a sale by Lisa C. McClain (house, MI), dated 31 Oct 2025.

Date Member Type Amount
31 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
30 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
30 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings